| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6189801 | Brachytherapy | 2013 | 7 Pages |
Abstract
The final toxicity analysis from ASBS breast brachytherapy registry trial confirms the previously noted excellent cosmesis and toxicity profiles and fails to confirm retrospective claims analyses that have suggested higher rates of toxicity for brachytherapy-based APBI.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Chirag Shah, Shariq Khwaja, Shahed Badiyan, J. Ben Wilkinson, Frank A. Vicini, Peter Beitsch, Martin Keisch, Douglas Arthur, Maureen Lyden,